• Home
  • About
  • Drug Development Pipeline
  • News
  • Investors
  • Careers
  • Contact
  • TSX.V: RKV
  • FSE: 7JO0
  • OTCMKTS: RKVTF

Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update

by Rakovina Therapeutics | Apr 30, 2026 | Uncategorized

download VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, today announced its financial...

Rakovina Therapeutics Presents New Preclinical Data at AACR 2026 Annual Meeting

by Rakovina Therapeutics | Apr 22, 2026 | Uncategorized

DOWNLOAD AI-Designed Dual ATR-mTOR Inhibitor Demonstrates In Vivo Efficacy; Novel LNP Formulation of Bifunctional PARP/HDAC Inhibitor kt-3283 Successfully Characterized VANCOUVER, British Columbia, April 22, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc....

Rakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 – World’s Premier Cancer Research Forum

by Rakovina Therapeutics | Mar 23, 2026 | Uncategorized

Accepted Abstracts Highlight Advances in AI-Driven Oncology Pipeline DOWNLOAD VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies...

Rakovina Therapeutics Announces Extension of Non-Brokered Private Placement

by Rakovina Therapeutics | Mar 12, 2026 | Uncategorized

DOWNLOAD VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, is pleased to announce that the TSXV...

Rakovina Therapeutics Announces Closing of $1 Million Debenture Unit Private Placement and Debt Settlement Agreements

by Rakovina Therapeutics | Mar 10, 2026 | Uncategorized

DOWNLOAD VANCOUVER, British Columbia, March 5, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, is pleased to announce closing of its...

Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million

by Rakovina Therapeutics | Feb 23, 2026 | Uncategorized

DOWNLOAD Proposed $1.0 Million Convertible Debenture and Warrant Financing andConcurrent Common Share Private Placement Up to $1.0 MillionIntended to Support Near-Term Operations Vancouver, British Columbia – February 20, 2026 – Rakovina Therapeutics Inc. (TSX-V:...
« Older Entries
Next Entries »

Suite 720, 999 West Broadway, Vancouver, British Columbia
Canada V5Z 1K5

Home

About

Drug Development Pipeline

News

Investors

Careers

Contact

Company Disclosure

Privacy Policy

Subscribe

To Receive Company Updates

Copyright ©2020-2026 Rakovina Therapeutics Inc. All rights reserved.  | Privacy Policy | Terms of Use |  Site by Vanooms Media